Presentation AHA 2024 Catheter Ablation or Antiarrhythmic Drug Therapy for Ventricular Tachycardia in Ischemic Cardiomyopathy: The VANISH2 Trial Presenter: John Sapp November 16, 2024
Presentation TCT 2024 TCT 1377: Mitral Valve Transcatheter Edge-to-Edge Repair for Hypertrophic Obstructive Cardiomyopathy Presenter: Konstantinos Voudris October 30, 2024
Presentation TCT 2024 TCT 254: Importance of Change in LVEF with PCI on Risk of Cardiac Death or Hospitalization for Heart Failure in Pateients With Stable Ischemic Cardiomyopathy Presenter: Stephen Ellis October 29, 2024
Presentation TCT 2024 TCT 255: Identifying Patients With Stable Ischemic Cardiomyopathy Whose LVEF Will Increase After PCI Presenter: Stephen Ellis October 29, 2024
Presentation TCT 2024 After REVIVED: When and How Should I Revascularize Patients With Cardiomyopathy and Coronary Artery Disease? Presenter: Margaret McEntegart October 29, 2024
Presentation TCT 2024 Case Presentation: Cardiogenic Shock in a Patient With Non-ischemic Cardiomyopathy Presenter: Ann Gage October 29, 2024
Presentation TCT 2024 TCT 792: Prognosis in Patients With Cardiogenic Shock According to Sex, With or Without Ischemic Cardiomyopathy Presenter: CHANG HOON KIM October 29, 2024
Presentation TCT 2024 Controlled Pulmonary Banding for Dilated Cardiomyopathy: the Restore Medical Approach Presenter: Sean Pinney October 28, 2024
Presentation TCT 2024 TCT 669: Impact of Epilepsy on In-Hospital Outcomes in Patients With Takotsubo Cardiomyopathy: A National Inpatient Sample Analysis Presenter: Anusha Kavarthapu October 27, 2024
Presentation TCT 2024 TCT 672: High Mortality and Complications in Patients Admitted With Takotsubo Cardiomyopathy Without Improvement in Outcomes Over the Years Presenter: Mohammad Reza Movahed October 27, 2024
Presentation TCT 2024 TCT 475: Long-Term Outcomes of Simultaneous Interventional Treatment for Hypertrophic Obstructive Cardiomyopathy and Concomitant Coronary Artery Disease Presenter: Stanislav Fanta October 27, 2024
Presentation TCT 2024 TCT 478: Socioeconomic Disparities in Patients Undergoing Alcohol Septal Ablation in Hypertrophic Obstructive Cardiomyopathy: A 5-Year National Experience Presenter: Himaja Dutt Chigurupati October 27, 2024
Presentation TCT 2024 TCT 479: Incomplete Resolution of Left Ventricular Outflow Tract Gradient After Alcohol Septal Ablation Is Predictive of Need for Reintervention in Hypertrophic Obstructive Cardiomyopathy: A Retrospective Cohort Study Presenter: Kylie Duckworth October 27, 2024
Presentation TCT 2024 TCT 477: Procedural Outcomes in 25 Years of Alcohol Septal Ablations at a Tertiary Level Medical Center Presenter: Nikhil Rao October 27, 2024
Presentation TCT 2024 TCT 879: Perioperative and In-Hospital Outcomes of Dilated Cardiomyopathy in Patients Undergoing Transcatheter Aortic Valve Replacement: A Large Cross-Sectional Study Using National Inpatient Sample Presenter: Ankur Singla October 27, 2024
Presentation NY Valves 2024 Interventional Approaches to Septal Reduction Therapy Presenter: Srihari S. Naidu June 07, 2024
Presentation NY Valves 2024 Is there Still a Role for Surgery in HCM? Presenter: Hiroo Takayama June 07, 2024
Presentation NY Valves 2024 Myosin Inhibitors and Novel Medical Therapies for HCM Presenter: Mark V. Sherrid June 07, 2024
Presentation NY Valves 2024 The SESAME Procedure for Obstructive HCM. Presenter: Jaffar M. Khan June 07, 2024
Presentation NY Valves 2024 A Clinical Approach to Genetics in Hypertrophic Cardiomyopathy Presenter: Martin Maron June 07, 2024